Lipopolysaccharide induced expression of peroxiredoxin 1 in airway epithelial cell

Chinese Critical Care Medicine

Volumn 25, Issue 3, 2013, Pages 136-139

  Liu, Yi Ting ^a   Mao, Pu ^a   Liu, Xiao Qing ^a   He, Wei Qun ^a   Mo, Hong Ying ^a   Li, Yi Min ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Human airway epithelial cell; Lipopolysaccharide; Peroxiredoxin 1

Indexed keywords

LIPOPOLYSACCHARIDE; MESSENGER RNA; PEROXIREDOXIN 1;

ARTICLE; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELL LINE; EPITHELIAL CELLS; HUMANS; LIPOPOLYSACCHARIDES; PEROXIREDOXINS; RESPIRATORY SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84887428738     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.2095-4352.2013.03.005     Document Type: Article

References (19)

1. Neumann CA, Cao J, Manevich Y. Peroxiredoxin 1 and its role in cell signaling. Cell Cycle, 2009,8:4072-4078.
2. Jamaluddin M, Wiktorowicz JE, Soman KV, et al. Role of peroxiredoxin 1 and peroxiredoxin 4 in protection of respiratory syncytial virus-induced cysteinyl oxidation of nuclear cytoskeletal proteins. J Virol, 2010,84:9533-9545.
3. Triantafilou M, Brandenburg K, Kusumoto S, et al. Combinational clustering of receptors following stimulation by bacterial products determines lipopolysaccharide responses. Biochem J, 2004,381:527-536.
4. Lima Trajano ET, Sternberg C, Caetano M, et al. Endotoxin-induced acute lung injury is dependent upon oxidative response. Inhal Toxicol, 2011,23:918-926.
5. Nagata M. Inflammatory cells and oxygen radicals. Curr Drug Targets Inflamm Allergy, 2005,4:503-504.
6. 2, a necessary evil for cell signaling. Science, 2006,312:1882-1883.
7. Kaul N, Forman HJ. Activation of NF kappa B by the respiratory burst of macrophages. Free Radic Biol Med, 1996,21:401-405.
8. Wang X, Adler KB, Erjefalt J, et al. Airway epithelial dysfunction in the development of acute lung injury and acute respiratory distress syndrome. Expert Rev Respir Med, 2007,1:149-155.
9. Wood ZA, Schröder E, Robin Harris J, et al. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci, 2003,28:32-40.
10. Rabilloud T, Heller M, Gasnier F, et al. Proteomics analysis of cellular response to oxidative stress, evidence for in vivo overoxidation of peroxiredoxins at their active site. J Biol Chem, 2002,277:19396-19401.
11. Kang SW, Chae HZ, Seo MS, et al. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J Biol Chem, 1998,273:6297-6302.
12. Pak JH, Kim TI, Joon Kim M, et al. Reduced expression of 1-cys peroxiredoxin in oxidative stress-induced cataracts. Exp Eye Res, 2006,82:899-906. (Pubitemid 43170890)
13. Jang HH, Lee KO, Chi YH, et al. Two enzymes in one; two yeast peroxiredoxins display oxidative stress-dependent switching from a peroxidase to a molecular chaperone function. Cell, 2004,117:625-635. (Pubitemid 38692528)
14. Cao J, Schulte J, Knight A, et al. Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity. EMBO J, 2009,28:1505-1517.
15. Bast A, Fischer K, Erttmann SF, et al. Induction of peroxiredoxin I gene expression by LPS involves the Src/PI3K/JNK signalling pathway. Biochim Biophys Acta, 2010,1799:402-410.